"Hepatitis A Vaccines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, 
	MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, 
	which enables searching at various levels of specificity.
	
	
		
			
			
				Vaccines or candidate vaccines used to prevent infection with hepatitis A virus (HEPATOVIRUS).
    
			
			
				
				
					
						| Descriptor ID | 
										
							D022362
						 | 			
					
					
						| MeSH Number(s) | 
						
							 D20.215.894.899.955.395 
						 | 
					
					
						| Concept/Terms | 
						
							Hepatitis A Vaccines- Hepatitis A Vaccines
 - Vaccines, Hepatitis A
 - Hepatovirus Vaccines
 - Vaccines, Hepatovirus
 - Hepatitis A Vaccine
 - Vaccine, Hepatitis A
 
  
						 | 
					
					
				
			 
			
				Below are MeSH descriptors whose meaning is more general than "Hepatitis A Vaccines".
				
			 
			
			
				Below are MeSH descriptors whose meaning is more specific than "Hepatitis A Vaccines".
				
			 
		 
	 
 
                                        
                                            
	
	
		
			
			
					
				This graph shows the total number of publications written about "Hepatitis A Vaccines" by people in this website by year, and whether "Hepatitis A Vaccines" was a major or minor topic of these publications. 
				
					
                    To see the data from this visualization as text, 
click here. 
				 
                
			 	
			
			
			
			
				Below are the most recent publications written about "Hepatitis A Vaccines" by people in Profiles.
						
					
								- 
								
Older age is associated with peripheral blood expansion of na?ve B cells in HIV-infected subjects on antiretroviral therapy. PLoS One. 2014; 9(9):e107064.
															
								 
							
								- 
								
Interleukin-2 Increases CD4+ lymphocyte numbers but does not enhance responses to immunization: results of A5046s. J Infect Dis. 2003 Jan 15; 187(2):320-5.
															
								 
							
								- 
								
Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen. ACTG 375 team. AIDS Clinical Trials Group. AIDS. 2000 Jan 07; 14(1):11-21.